| Ytd | -45.43% | |
| 1y | -40.48% |
| Open | 5.32 | Prev Close | 5.28 | Low | 5.25 | High | 5.44 | Mkt Cap | 254.89M |
| Vol | 674.28K | Avg Vol | 657.26K | EPS | 1.08 | P/E | 4.86 | Forward P/E | 6.47 |
| Beta | 1.13 | Short Ratio | 1.83 | Inst. Own | 81.02% | Dividend | 0.24 | Div Yield | 3.64 |
| Ex Div Date | 11-29 | Earning | 08-06 | 50-d Avg | 6.06 | 200-d Avg | 8.81 | 1yr Est | 6.92 |
5 low price-to-sales stocks passed a value screen that combines valuation, debt and quality metrics
Nu Skin Enterprises (NUS) faces low profitability and macro-driven sales headwinds, with limited rec
EL, HELE, NUS, KVUE and IPAR stand out as beauty and cosmetics stocks backed by growth strategies fo
Nu Skin (NUS) witnessed a jump in share price last session on above-average trading volume. The late
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Nu Skin Enterprises (NYSE:NUS) lowers FY2026 GAAP EPS guidance from $0.80-$1.20 to $0.70-$1.10 vs $1
Nu Skin Enterprises (NYSE:NUS) is looking for Q2 GAAP EPS of $0.15-$0.25 vs $0.23 analyst estimate.
Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.14 per share which missed the analy
Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the appointment of Chelsea Lantz as interim Ch
Nu Skin Enterprises Inc. (NYSE:NUS) today announced the appointment of Chayce Clark as chief operati
Nu Skin Enterprises Inc (NYSE: NUS) reported Q4 2025 results that missed expectations, with EPS of 2
Nu Skin Enterprises (NYSE:NUS) sees FY2026 sales of $1.350 billion-$1.500 billion vs $1.530 billion
Nu Skin Enterprises (NYSE:NUS) sees Q1 sales of $320.000 million-$340.000 million vs $356.800 millio
Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.29 per share which missed the analy
Investors should avoid speculative assets and risky stocks in volatile markets. Safe-haven options l
Nu Skin Enterprises (NYSE:NUS) raises FY2025 GAAP EPS guidance from $3.05-$3.25 to $3.15-$3.25 vs $3
Nu Skin Enterprises (NYSE:NUS) raises FY2025 Adj EPS guidance from $1.15-$1.35 to $1.25-$1.35 vs $1.
Nu Skin Enterprises (NYSE:NUS) is looking for Q4 GAAP EPS of $0.25-$0.35 vs $0.33 analyst estimate.
Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.34 per share which beat the analyst
Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.43 per share which beat the analyst
Nu Skin Enterprises (NYSE:NUS) is looking for Q3 GAAP EPS of $0.25-$0.35 vs $0.29 analyst estimate.
Nu Skin Enterprises (NYSE:NUS) raises FY2025 GAAP EPS guidance from $2.80-$3.20 to $3.05-$3.20 vs $0
Nu Skin Enterprises (NYSE:NUS) raises FY2025 Adj EPS guidance from $0.90-$1.30 to $1.15-$1.35 vs $0.
Nu Skin Enterprises (NYSE:NUS) is looking for Q2 GAAP EPS of $0.20-$0.30 vs $0.24 analyst estimate.
Nu Skin Enterprises (NYSE:NUS) affirms FY2025 Adj EPS guidance from $0.90-$1.30 to $0.90-$1.30 vs $0
Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.23 per share which beat the analyst
Nu Skin's stock rose premarket on Friday following the announcement of its Rhyz subsidiary selli
Approximately $33 million of such consideration will be paid to other equity holders in the Mavely b
DA Davidson analyst Linda Bolton Weiser maintains Nu Skin Enterprises (NYSE:NUS) with a Neutral a
Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.17 per share which beat the analyst
MYND360 provides holistic, cognitive support for core areas of mental well-being, including sleep, c
DA Davidson analyst Linda Bolton Weiser maintains Nu Skin Enterprises (NYSE:NUS) with a Neutral a
Citigroup analyst Chasen Bender maintains Nu Skin Enterprises (NYSE:NUS) with a Neutral and lower
Nu Skin Enterprises (NYSE:NUS) reported quarterly earnings of $0.21 per share which beat the analyst
Jim Cramer, when asked about Albemarle, said "Anything connected with [electric vehicles] right
DA Davidson analyst Linda Bolton Weiser maintains Nu Skin Enterprises (NYSE:NUS) with a Neutral a
Nu Skin Enterprises (NYSE:NUS) reported quarterly losses of $(0.01) per share which missed the analy